Clinical Trials Logo

Hypothermia clinical trials

View clinical trials related to Hypothermia.

Filter by:

NCT ID: NCT00870610 Completed - Hypothermia Clinical Trials

Jugular Venous Oxygen Saturation During Therapeutic Hypothermia After Cardiac Arrest

SjO2
Start date: November 2011
Phase: N/A
Study type: Observational

The purpose of this study is to understand what happens to cerebral metabolism during therapeutic hypothermia for hypoxic brain injury following cardiac arrest.

NCT ID: NCT00843297 Completed - Cardiac Arrest Clinical Trials

COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest

COOL
Start date: April 2008
Phase: Phase 4
Study type: Interventional

Sudden cardiac arrest (SCA) remains one of the major leading causes of death. Cognitive deficits are common in survivors of SCA. Postresuscitative mild induced hypothermia (MIH) lowers mortality and reduces neurologic damage after cardiac arrest. The investigators evaluated the efficacy and side effects of therapeutic hypothermia in an unselected group of patients after SCA.

NCT ID: NCT00827957 Completed - Cardiac Arrest Clinical Trials

Comparing Therapeutic Hypothermia Using External and Internal Cooling for Post-Cardiac Arrest Patients

Hypothermia
Start date: October 2008
Phase: Phase 4
Study type: Interventional

Controlled therapeutic hypothermia is a method of preserving neurological function post-resuscitation.It has been associated with improved functional recovery and reduced histological deficits in animal models of cardiac arrest.

NCT ID: NCT00817401 Completed - Clinical trials for Hypoxic-Ischemic Encephalopathy

Systemic Hypothermia Improves Outcome of Hypoxic-Ischemic Encephalopathy

Start date: July 2002
Phase: Phase 1/Phase 2
Study type: Interventional

Perinatal asphyxia-induced brain injury is one of the most common causes of morbidity and mortality in term and preterm neonates. Birth asphyxia accounts for 23% of neonatal deaths globally and survivors suffer from long term neurological disability and impairment. Although many neuroprotective strategies appeared promising in animal models, most of them were not feasible and effective in human newborns. However, hypothermia was reported not to be effective if introduced beyond and thus should be introduced within 6 hrs after birth.Applying this selection criterion naturally would deprive many patients of the opportunity of hypothermia treatment.

NCT ID: NCT00801424 Completed - Hypothermia Clinical Trials

Warmed Humidified Carbon Dioxide (CO2) for Open Surgery

S2
Start date: November 2008
Phase: N/A
Study type: Interventional

Eighty adult patients undergoing open colon surgery will be randomized to either: 1. standard warming measures including heating sheets, warming of fluids, and insulation of limbs and head, or to 2. additional insufflation of humidified carbon dioxide (approx. 36-37ºC, approx. 80-100% relative humidity) via a humidifier with a heated tube (Fisher&Paykel) connected to a gas diffuser (Cardia Innovation AB) that is able to create a local atmosphere of 100% carbon dioxide (humidified ) in the open wound cavity. PRIMARY AIM The primary aim of this study is to evaluate if humidified carbon dioxide insufflated into an open surgical wound can be used to warm the core, the open wound cavity, and the wound edges during major abdominal surgery. SECONDARY AIMS Secondary aims are to evaluate possible differences between the groups regarding complications and clinical differences including histological signs of desiccation injury of peritoneal samples, time to extubation, core temperature after surgery, ICU stay, bleeding volume, hospital stay, postoperative pain, infections, shivering, postoperative signs of restored bowel function including bowel movements, flatus, and first meal.

NCT ID: NCT00797680 Completed - Cardiac Arrest Clinical Trials

Duration of Hypothermia for Neuroprotection After Pediatric Cardiac Arrest

Start date: October 2008
Phase: Phase 2
Study type: Interventional

In this study, children who survive cardiac arrest will be evaluated whether 24 or 72 hours of whole body hypothermia (cooling) during recovery is better to help prevent brain injury and improve outcome. The investigators will also test the safety of cooling patients for 24 and 72 hours. The investigators hypothesize that 72 hours of cooling will be more beneficial than 24 hours without compromising safety.

NCT ID: NCT00772460 Completed - Hypothermia Clinical Trials

Comparison of a New Patient Warming System Using Polymer Conductive Warming With Forced Air Warming During Surgery

HDV
Start date: October 2008
Phase: Phase 3
Study type: Interventional

Two patient warming systems will be compared with 40 patients each in a convective warming group (BairHugger, Arizant) and in a conductive warming group (HotDog, Augustine Biomedical). The patients will undergo small to medium trauma surgery and will be warmed with the randomized device - the hypothesis is, that the area under the standardized core temperature / time curve is significantly greater in the conductive warming group. Secondary outcome is the mean skin temperature / time area under the curve.

NCT ID: NCT00766103 Completed - Clinical trials for Cerebral Metabolism and Perfusion

The Effects of PaCO2 Levels on Cerebral Metabolism and Perfusion During Induced Hypothermia.

Start date: December 2006
Phase: N/A
Study type: Interventional

Incidence of hypo- and hypercarbia during induced hypothermia after cardiac arrest is high. The original report from HACA-group reported that hypothermia treated patients had improved survival and neurological outcome. Suprisingly, in that trial normocarbia was not achieved even though the aim was set for ventilatory support as normoventilation. This study aims to investigate the effects of mild hypo- and hypercarbia on cerebral perfusion (blood flow, intracranial pressure) and metabolism (microdialysate metabolites). We hypothesize that uncontrolled ventilatory suppport may render the patients in risk of exacerbation of neuronal damage, conversely, further improvement in outcome may be achieved with succesfull ventilatory management. We intend to enroll 10 out-of-hospital cardiac arrest patients succesfully resuscitated and subsequently treated with controlled hypothermia for 24 hours. The patients in need of anticoagulation are excluded. We plan to induce mild hypocarbia and hypercarbia during and after induced hypothermia. Metabolic and perfusion data are collected with clinically used methods such as transcranial doppler, intracranial pressure measurement, near infrared spectroscopy, jugular bulb, intracerebral microdialysis).

NCT ID: NCT00754481 Completed - Cardiac Arrest Clinical Trials

Hypothermia for Cardiac Arrest in Paediatrics

Start date: January 2005
Phase: Phase 2
Study type: Interventional

The investigators hypothesized that, following cardiac arrest in pediatric patients, hypothermia therapy will improve the proportion of patients with a good functional outcome compared to a normothermic control group.

NCT ID: NCT00712023 Completed - Hypothermia Clinical Trials

Effect of Forced-air Warming and Circulating-water Mattress in Preventing Heat Loss During Vascular Surgery

Start date: July 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a custom-made forced-air warming mattress can prevent heat loss in patients undergoing vascular surgery better than a circulating-water mattress